Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pertussis Infection”

375 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 375 results

Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Not applicableLooking for participantsNCT06466629
What this trial is testing

The Optimal Timing of Vaccination in Pregnancy

Who this might be right for
Pertussis/Whooping Cough
Elke Leuridan, MD, PhD 96
Testing effectiveness (Phase 2)UnknownNCT02813486
What this trial is testing

Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine

Who this might be right for
TetanusDiphtheriaWhooping Cough
Green Cross Corporation 220
Not applicableStudy completedNCT07444502
What this trial is testing

Safety Monitoring of Boostagen® Vaccine in Thailand

Who this might be right for
Pertussis (Whooping Cough)TetanusDiphtheria
BioNet-Asia Co., Ltd. 10,727
Early research (Phase 1)Looking for participantsNCT06184542
What this trial is testing

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Who this might be right for
DiphtheriaTetanusPertussis
Institute of Medical Biology, Chinese Academy of Medical Sciences 460
Large-scale testing (Phase 3)Study completedNCT01034254
What this trial is testing

Field Trial of Maternal Influenza Immunization in Asia

Who this might be right for
Influenza Human
Children's Hospital Medical Center, Cincinnati 3,693
Large-scale testing (Phase 3)Study completedNCT00662870
What this trial is testing

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi 1,941
Testing effectiveness (Phase 2)WithdrawnNCT01110044
What this trial is testing

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT01988857
What this trial is testing

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 302
Large-scale testing (Phase 3)Study completedNCT00467519
What this trial is testing

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Who this might be right for
TetanusDiphtheriaPertussis
Sanofi Pasteur, a Sanofi Company 1,045
Large-scale testing (Phase 3)Study completedNCT00348881
What this trial is testing

Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 2,133
Testing effectiveness (Phase 2)Study completedNCT00376779
What this trial is testing

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Who this might be right for
Acellular PertussisTetanusDiphtheria+3 more
GlaxoSmithKline 450
Testing effectiveness (Phase 2)Study completedNCT00317174
What this trial is testing

Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Who this might be right for
Haemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more
GlaxoSmithKline 450
Not applicableStudy completedNCT00258882
What this trial is testing

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

Who this might be right for
Pertussis
Sanofi Pasteur, a Sanofi Company 327,293
Large-scale testing (Phase 3)Study completedNCT01767376
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 692
Testing effectiveness (Phase 2)Study completedNCT05662852
What this trial is testing

Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors

Who this might be right for
Tetanus, Diphtheria and Acellular Pertussis Vaccination
ABO Holdings, Inc. 100
Large-scale testing (Phase 3)Study completedNCT02817451
What this trial is testing

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 53
Not applicableStudy completedNCT02112890
What this trial is testing

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

Who this might be right for
Hepatitis AViral Hepatitis Vaccines
GlaxoSmithKline 1,603
Not applicableStudy completedNCT02862262
What this trial is testing

A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients

Who this might be right for
Bordetella InfectionsBordetella Pertussis InfectionBordetella Parapertussis Infection
Luminex Molecular Diagnostics 1,052
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Load More Results